Mizuho Securities USA LLC Buys 73,149 Shares of McKesson Co. (NYSE:MCK)

Mizuho Securities USA LLC increased its holdings in shares of McKesson Co. (NYSE:MCK - Free Report) by 730.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,170 shares of the company's stock after purchasing an additional 73,149 shares during the period. Mizuho Securities USA LLC owned approximately 0.06% of McKesson worth $41,121,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. LRI Investments LLC bought a new stake in shares of McKesson during the first quarter worth $28,000. Wolff Wiese Magana LLC raised its stake in shares of McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company's stock valued at $29,000 after purchasing an additional 52 shares during the period. ORG Wealth Partners LLC bought a new stake in shares of McKesson in the third quarter valued at about $40,000. Carmichael Hill & Associates Inc. acquired a new position in shares of McKesson during the second quarter worth about $52,000. Finally, Centennial Bank AR bought a new position in shares of McKesson during the second quarter worth about $53,000. 85.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MCK. Evercore ISI raised their target price on shares of McKesson from $560.00 to $680.00 and gave the company an "outperform" rating in a research report on Thursday, November 7th. Barclays raised their target price on shares of McKesson from $596.00 to $616.00 and gave the company an "overweight" rating in a research note on Thursday, August 8th. Baird R W upgraded shares of McKesson from a "hold" rating to a "strong-buy" rating in a research note on Thursday, November 7th. Wells Fargo & Company dropped their target price on shares of McKesson from $576.00 to $535.00 and set an "equal weight" rating on the stock in a report on Friday, September 13th. Finally, Leerink Partners cut their price objective on McKesson from $665.00 to $630.00 and set an "outperform" rating for the company in a research report on Monday, October 7th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $631.57.

McKesson Stock Performance

Shares of MCK traded down $3.87 during mid-day trading on Friday, reaching $606.29. The company had a trading volume of 1,008,159 shares, compared to its average volume of 824,784. The company has a market capitalization of $76.96 billion, a price-to-earnings ratio of 31.40, a P/E/G ratio of 1.35 and a beta of 0.44. The company's 50 day simple moving average is $520.01 and its 200 day simple moving average is $554.29. McKesson Co. has a 1-year low of $431.35 and a 1-year high of $637.51.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating analysts' consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The firm had revenue of $93.65 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same quarter last year, the business posted $6.23 earnings per share. The company's quarterly revenue was up 21.3% on a year-over-year basis. As a group, equities analysts forecast that McKesson Co. will post 32.81 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Monday, December 2nd. McKesson's payout ratio is 14.71%.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the transaction, the chief executive officer now owns 78,586 shares in the company, valued at approximately $44,094,604.60. The trade was a 4.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.11% of the company's stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.